1066 Stock Overview
Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Shandong Weigao Group Medical Polymer Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$5.07 |
| 52 Week High | HK$6.54 |
| 52 Week Low | HK$3.60 |
| Beta | 0.46 |
| 1 Month Change | 4.32% |
| 3 Month Change | 12.67% |
| 1 Year Change | 0.20% |
| 3 Year Change | -50.78% |
| 5 Year Change | -55.05% |
| Change since IPO | -2.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1066 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -1.4% | -1.6% | -2.3% |
| 1Y | 0.2% | 1.6% | 25.0% |
Return vs Industry: 1066 underperformed the Hong Kong Medical Equipment industry which returned 6.9% over the past year.
Return vs Market: 1066 underperformed the Hong Kong Market which returned 28.6% over the past year.
Price Volatility
| 1066 volatility | |
|---|---|
| 1066 Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in HK Market | 14.1% |
| 10% least volatile stocks in HK Market | 3.1% |
Stable Share Price: 1066 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1066's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 12,606 | Rinan Cong | www.weigaogroup.com |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables.
Shandong Weigao Group Medical Polymer Company Limited Fundamentals Summary
| 1066 fundamental statistics | |
|---|---|
| Market cap | HK$23.17b |
| Earnings (TTM) | HK$2.04b |
| Revenue (TTM) | HK$13.86b |
11.3x
P/E Ratio1.7x
P/S RatioIs 1066 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1066 income statement (TTM) | |
|---|---|
| Revenue | CN¥12.97b |
| Cost of Revenue | CN¥6.52b |
| Gross Profit | CN¥6.44b |
| Other Expenses | CN¥4.53b |
| Earnings | CN¥1.91b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.42 |
| Gross Margin | 49.69% |
| Net Profit Margin | 14.74% |
| Debt/Equity Ratio | 16.3% |
How did 1066 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield44%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/28 06:05 |
| End of Day Share Price | 2025/02/28 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Weigao Group Medical Polymer Company Limited is covered by 36 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Mann | Barclays |
| Derrick Sun | BNP Paribas Securities (Asia) |
| Jessica Li | BofA Global Research |